NCT06981936View on ClinicalTrials.gov

This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Micronutrient Deficiencies
Interventions
DRUG

Balance Tablet

Each Balance tablet contains a broad range of vitamins and trace minerals at doses designed to prevent deficiencies (including but not limited to vitamins A, B-complex, C, D, E, K, calcium, iron, zinc, magnesium, selenium, and others, per standard multivitamin composition).

DRUG

Control (placebo)

The placebo is an inert pill formulated to be indistinguishable from the Balance tablet in appearance, weight, and taste.

Trial Locations (1)

Unknown

RECRUITING

Facility Name: The surgical department of Medical Research Institute Hospital, Alexandria University, Alexandria, Facility, Alexandria

All Listed Sponsors
lead

General Committee of Teaching Hospitals and Institutes, Egypt

OTHER_GOV